Clinical Trial Update: A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating riociguat for pulmonary hypertension associated with left ventricular systolic dysfunction has completed, with results posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Left Ventricular Systolic Dysfunction
• Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary, Ventricular Dysfunction, Left | Phase 2 | Status: COMPLETED | Results posted: 2013-12-25